CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-09 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Sale | −59,397 | $156.27 | $9.3M | 141,416 |
| 2024-02-09 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Option exercise · Employee Stock Options (Right to Buy) | −59,397 | 0 | ||
| 2024-02-08 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Option exercise | +3,739 | 143,329 | ||
| 2024-02-08 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Shares withheld for taxes | −1,913 | $156.33 | $299K | 141,416 |
| 2024-02-08 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Option exercise · Restricted Share Units | −3,739 | 0 | ||
| 2024-02-08 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +1,971 | 67,904.87 | ||
| 2024-02-08 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −1,009 | $156.33 | $158K | 66,895.87 |
| 2024-02-08 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Restricted Share Units | −1,971 | 0 | ||
| 2024-02-08 | Wolk Joseph J Exec VP, CFO | Option exercise | +3,686 | 53,911 | ||
| 2024-02-08 | Wolk Joseph J Exec VP, CFO | Shares withheld for taxes | −1,047 | $156.33 | $164K | 52,864 |
| 2024-02-08 | Wolk Joseph J Exec VP, CFO | Option exercise · Restricted Share Units | −3,686 | 0 | ||
| 2024-02-08 | Swanson James D. See Remarks | Option exercise | +1,868 | 11,111 | ||
| 2024-02-08 | Swanson James D. See Remarks | Shares withheld for taxes | −554 | $156.33 | $87K | 10,557 |
| 2024-02-08 | Swanson James D. See Remarks | Option exercise · Restricted Share Units | −1,868 | 0 | ||
| 2024-02-08 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +5,225 | 310,583 | ||
| 2024-02-08 | Duato Joaquin CEO and Chairman of the Board | Shares withheld for taxes | −2,269 | $156.33 | $355K | 308,314 |
| 2024-02-08 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Restricted Share Units | −5,225 | 0 | ||
| 2024-02-08 | Forminard Elizabeth Executive VP, General Counsel | Option exercise | +979 | 6,463 | ||
| 2024-02-08 | Forminard Elizabeth Executive VP, General Counsel | Shares withheld for taxes | −363 | $156.33 | $57K | 6,100 |
| 2024-02-08 | Forminard Elizabeth Executive VP, General Counsel | Option exercise · Restricted Share Units | −979 | 0 |
Page 32 of 33 · 658 trades